Reduction of symptoms with the SECUADO® patch compared to placebo (non-medicated patch) after 6 weeks
PANSS total score improvement vs placebo
How might SECUADO® help?
In a medical study of more than 600 adults, SECUADO® helped people living with schizophrenia manage their symptoms. At the end of this 6-week study, the symptoms of people using SECUADO® improved significantly.
The active ingredient in SECUADO®, asenapine, has been available in the United States for over 10 years.
What is treatment success?
Among the symptoms of schizophrenia are positive symptoms (such as hallucinations and delusions) and negative symptoms (such as lack of interest or motivation). In the SECUADO clinical study, the Positive and Negative Syndrome Scale was used to measure treatment success.
You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven